Culturally Targeted SARS-CoV-2 Communication for COVID-19

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Flint Journal Building, Flint, MICOVID-19Culturally Targeted SARS-CoV-2 Communication - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will focus on how to best communicate with African Americans in Flint, Michigan about getting a SARS-CoV-2 antibody test through a drive-up saliva sample collection.

Eligible Conditions
  • COVID-19

Treatment Effectiveness

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: up to 8 weeks

Hour 1
Anticipatory Racism
Theory of Planned Behavior Antibody Testing Outcomes
up to 2 weeks
Salivary Kit Request
up to 8 weeks
Salivary Kit Completion

Trial Safety

Trial Design

3 Treatment Groups

African American Registry: General
1 of 3
White Flint Registry: General
1 of 3
African American Registry: Culturally Targeted
1 of 3

Active Control

Experimental Treatment

500 Total Participants · 3 Treatment Groups

Primary Treatment: Culturally Targeted SARS-CoV-2 Communication · No Placebo Group · N/A

African American Registry: Culturally Targeted
Behavioral
Experimental Group · 1 Intervention: Culturally Targeted SARS-CoV-2 Communication · Intervention Types: Behavioral
African American Registry: General
Behavioral
ActiveComparator Group · 1 Intervention: General SARS-CoV-2 Communication · Intervention Types: Behavioral
White Flint Registry: General
Behavioral
ActiveComparator Group · 1 Intervention: General SARS-CoV-2 Communication · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 8 weeks

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,153 Previous Clinical Trials
41,161,808 Total Patients Enrolled
36 Trials studying COVID-19
1,900,231 Patients Enrolled for COVID-19
Michigan State UniversityLead Sponsor
168 Previous Clinical Trials
597,832 Total Patients Enrolled
Johns Hopkins UniversityOTHER
2,093 Previous Clinical Trials
31,769,025 Total Patients Enrolled
29 Trials studying COVID-19
17,849,711 Patients Enrolled for COVID-19

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You identify as either African American or White.

Frequently Asked Questions

How many participants has the trial accepted thus far?

"Affirmative, the information found on clinicaltrials.gov suggests that this research is currently recruiting participants. This scientific investigation was initially posted on August 4th 2021 and has since been updated as of December 3rd 2021, aiming to recruit 500 subjects from a single medical facility." - Anonymous Online Contributor

Unverified Answer

Are there any available vacancies in this medical experiment?

"Affirmative. According to the records on clinicaltrials.gov, this research study is currently recruiting participants which began listing on August 4th 2021 and was updated lastly on December 3rd 2021. For completion of the trial, 500 patients are needed from a single site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.